Appointment booking for Dr. James Hueftle, MD is currently not available.Dr. James Hueftle, MD has not yet fully activated their profile on DiabetesIQ.
Dr. James Hueftle, MD (he/him) is a Oncologist in Anaconda, MT with over 18 years of experience. What is your opinion of Dr. James Hueftle, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. James Hueftle, MD has received over $7,420 which includes payments from the following companies:
$1,183.90 from Genentech USA, Inc.
$1,072.55 from Amgen Inc.
$911.69 from Novartis Pharmaceuticals Corporation
$679.73 from AstraZeneca Pharmaceuticals LP
$451.82 from E.R. Squibb & Sons, L.L.C.
$350.22 from Alexion Pharmaceuticals, Inc.
$346.21 from Pfizer Inc.
$303.41 from Incyte Corporation
$280.97 from Merck Sharp & Dohme Corporation
$234.69 from TESARO, Inc.
$196.38 from Astellas Pharma US Inc
$164.91 from Eisai Inc.
$134.06 from Seattle Genetics, Inc.
$128.83 from GENZYME CORPORATION
$113.57 from Exelixis Inc.
$112.24 from Gilead Sciences Inc
$97.76 from LILLY USA, LLC
$93.70 from Helsinn Therapeutics (U.S.), Inc.
$79.40 from Pharmacyclics LLC, An AbbVie Company
$69.67 from Celgene Corporation
Payments received by Dr. James Hueftle, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!